A Report of Development of Pharmaceutical Industry in Jiangsu Province in 2013
CHU Shuzhen;SUN Zhenlin;CHEN Lu;Research Center of Pharmaceutical Industry in China Pharmaceutical University;

..............page:321-328

A Report of Drug Registration Management in Jiangsu Province in 2013
WANG Zongmin;DING Guirong;Jiangsu Provincial Food and Drug Administration;

..............page:329-332

Advances in Research on Bcr-Abl Tyrosine Kinase Inhibitors against T315I Mutation1,2221
YE Jiawei;ZHAO Liwen;ZHANG Cang;YOU Qidong;Department of Medicinal Chemistry;China Pharmaceutical University;Nanjin Sanhome Pharmaceutical Co.;Ltd.;

..............page:333-339

yao xue jin zhan za zhi 2014 nian zheng ding qi shi

..............page:339

Advances in Research on Marine Bioactive Compound Fascaplysin
DANG Zhu;ZHU Haijing;JIAO Yu;LU Tao;School of Science;China Pharmaceutical University;The No.2 Artillery General Hospital of Chinese People’s Liberation Army;

..............page:340-348

chinese journal of natural medicines 2014 nian zheng ding qi shi

..............page:348

Activating Transcription Factor 6:a New Potential Target against Type 2 Diabetes
CHENG Yanhua;ZHOU Jinpei;ZHANG Huibing;Department of Medicinal Chemistry;China Pharmaceutical University;

..............page:349-354

Uric Acid Metabolism Disturbance and Cardiovascular Diseases:Drug Interference
LIU Yao;HE Hua;LI Xi;WANG Shijun;LIU Xiaoquan;TANG Yiqun;Center of Drug Metabolism and Pharmacokinetics;China Pharmaceutical University;Department of Clinical Pharmacology;China Pharmaceutical University;

..............page:355-361

yao xue jin zhan zai guo nei 66 zhong yao xue lei qi kan zhong pian jun xia zai liang pai ming di 1 wei
ben kan bian ji bu ;

..............page:361

Pharmacoeconomic Evaluation on Chemotherapy Combined with Rituximab for the Treatment of NonHodgkin’s Lymphoma
LI Qian;MA Aixia;School of International Pharmaceutical Business;China Pharmaceutical University;

..............page:362-369

A Report of New Drugs Research and Development in 2013——Part I:New Drugs & Biologics(III)
Graul A I;Cruces E;Stringer M;

..............page:370-379

zhong guo yao xue nian jian 2013 juan zheng ding qi shi

..............page:379

Developments in Clinical Trials:Adaptive Designs and Transparancy
Thomson Reuters;

..............page:380-387

guo ji xin yao yan fa dong tai
wu feng juan ; wang zuo ; cai dan ning ;

..............page:388-391

Analysis of Important Targets in National Key Subject of Drug Innovation——Receptor Tyrosine Kinase c-Met
YANG Zhenzheng;XING Aimin;ZHENG Xiaonan;Editorial Offi ce of Progress in Pharmaceutical Sciences;

..............page:392-400